Related Experiment Video
Updated: Jul 2, 2025
09:46
Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
Published on: February 26, 2021
3.2K
Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease.
Valeriia Klymenko1, Orlando G González Martínez1, Marco Zarbin1
1Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Rutgers University, Newark, NJ, USA.
Stem Cells Translational Medicine
|February 23, 2024
Summary
Retinal pigment epithelium transplantation shows promise for treating degenerative retinal diseases like macular degeneration and retinitis pigmentosa. Ongoing clinical trials and preclinical research are addressing key challenges for successful cell therapy.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Therapy
Background:
- Age-related macular degeneration and retinitis pigmentosa cause significant vision loss.
- Current treatments are limited, necessitating novel therapeutic approaches.
Approach:
- This review summarizes advancements in retinal pigment epithelium transplantation.
- It covers preclinical studies and clinical trial outcomes.
Key Points:
- Focus on transplant immunology, cell delivery methods, and cell manufacturing.
- Highlights progress in overcoming challenges for retinal cell transplantation.
Conclusions:
- Retinal pigment epithelium transplantation is a developing treatment for degenerative retinal diseases.
- Further research is crucial for optimizing cell therapy efficacy and safety.
Keywords:
cell transplantationembryonic stem cellsgeographic atrophyinduced pluripotent stem cellsmacular degenerationretinaretinal pigment epitheliumretinitis pigmentosa
